Mulpleta

Indicated For

thrombocytopenia in chronic liver disease patients scheduled for procedures

About This Medication

# Mulpleta Assist Patient Guide: How to Get Mulpleta (lusutrombopag) at Low or No Cost Mulpleta (lusutrombopag) is a prescription medication used to treat low platelet counts (thrombocytopenia) in adults with chronic liver disease who are scheduled for a procedure, and **Mulpleta Assist** is Shionogi's patient support program to help access it affordably[1][2][3]. This guide explains eligibility, application steps, and support options in simple terms to empower you as a patient. ## About Mulpleta and Why It's Needed **Mulpleta** is an oral tablet that acts as a thrombopoietin receptor agonist, helping your body produce more platelets before a procedure to reduce bleeding risk[2]. It's for adults (18+) with chronic liver disease (CLD) and a platelet count below 50 x 10^9/L, taken as 3 mg once daily for 7 days, starting 8-14 days before your scheduled procedure and with the procedure occurring 2-8 days after the last dose[2][5][7]. Unlike platelet transfusions, Mulpleta stimulates your own platelet production and is FDA-approved since 2018[3]. It's not for normalizing platelet counts long-term but specifically for procedure prep[6]. Common in CLD patients, low platelets increase bleeding risks during invasive procedures like biopsies or surgeries[1]. Always follow your doctor's guidance, as Mulpleta has specific safety considerations listed in its prescribing information[2]. ## Who Qualifies for Mulpleta Assist? Mulpleta Assist is Shionogi's **full-service patient access program** offering dedicated support for medication logistics, reimbursement coordination, financial assistance matching, and overall patient help[1][3]. It targets patients facing access or affordability barriers, especially those with commercial insurance, Medicare, Medicaid, or no coverage. While exact income thresholds aren't publicly detailed, programs like this typically assist uninsured/underinsured patients meeting financial need criteria (often 400-500% of Federal Poverty Level, or FPL), but contact the program for your situation[1]. Qualification generally requires: - A valid Mulpleta prescription for FDA-approved use (thrombocytopenia in CLD adults pre-procedure). - Proof of financial hardship or insurance denial. - U.S. residency. Healthcare providers can also enroll patients via the program for streamlined support[3]. ## Income Eligibility Breakdown Specific income limits for Mulpleta Assist aren't detailed in public sources, so eligibility is determined case-by-case based on household income, size, and expenses[1]. Similar Shionogi programs and industry standards often use FPL guidelines. Here's a general table for context (adjust for 2026 FPL; verify with program): | Household Size | 400% FPL Example (Annual Income) | 500% FPL Example (Annual Income) | |---------------|---------------------------------|---------------------------------| | 1 (Individual) | ~$60,000 | ~$75,000 | | 2 (Couple) | ~$81,000 | ~$101,000 | | 3 | ~$102,000 | ~$127,000 | | 4 | ~$122,000 | ~$153,000 | **Notes**: These are illustrative; Mulpleta Assist may cover up to certain FPL percentages or offer copay cards for insured patients. Higher incomes may qualify via insurance coordination. Call for exact thresholds[1][3]. ## Insurance Requirements Mulpleta often requires **prior authorization (PA)** from insurers like Aetna, Cigna, UnitedHealthcare, and others, confirming platelet count <50 x 10^9/L, age 18+, procedure timing, and specialist involvement (e.g., hematologist/hepatologist)[4][5][6][7][10]. Medicare Part D may cover it with PA; Medicaid varies by state. Mulpleta Assist helps with PA appeals, benefits investigations, and bridging free medication if delayed[3]. Uninsured patients get direct assistance matching. No insurance? The program coordinates affordability options[1]. ## Step-by-Step Application Process 1. **Get Prescribed**: Ask your doctor (ideally hematologist/hepatologist) for Mulpleta and discuss Mulpleta Assist[6]. 2. **Contact Mulpleta Assist**: Call the dedicated support line (available via Shionogi; check prescribing materials or provider portal) or have your doctor initiate[1][3]. 3. **Submit Application**: Provide prescription, proof of income (tax returns, pay stubs), insurance details/denial, ID, and procedure schedule. Your provider may handle via electronic portal[3]. 4. **Benefits Investigation**: Program verifies coverage and matches assistance (copay help, free drug, reimbursement)[1]. 5. **Approval Notification**: Receive confirmation; sign any agreements. 6. **Receive Medication**: Shipped to your home or pharmacy pre-procedure[3]. Your healthcare team can lead this for ease. ## Timeline and Delivery **Processing**: Expect 1-5 business days for initial review, longer if PA needed (insurers take 7-14 days)[3][10]. Start early—Mulpleta dosing begins 8-14 days pre-procedure[2]. **Delivery**: Free shipping to your home or doctor's office via specialty pharmacy; trackable[1]. If urgent, bridge supply possible. Plan for reauthorization per procedure cycle[10]. ## Alternatives if Denied or Other Options If denied: - Appeal via Mulpleta Assist (they assist with documentation)[3]. - **Alternatives**: Platelet transfusions (traditional but invasive), other TPO agonists like Nplate/Provayle (different indications), or procedure delay[2]. No biosimilars listed[2]. Patient Access Networks (PAN) or NeedyMeds for general aid. - State programs or manufacturer copay cards. Discuss with your doctor; Mulpleta Assist explores all avenues[1]. ## Important Disclaimer This guide is for informational purposes based on available data as of 2026 and not medical/financial advice. Eligibility, terms, and availability change; **always contact Mulpleta Assist directly** or consult your healthcare provider/insurer for personalized details. Shionogi may update the program. Not guaranteed coverage. See full prescribing info for risks (e.g., thrombosis)[2]. Word count: 1028.

Program information last verified: March 30, 2026